Related Experiment Video
Updated: Jan 3, 2026

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR
Published on: February 4, 2018
Increasing Burden of Lyme Carditis in United States Children's Hospitals
Cheyenne M Beach1, Stephen A Hart2, Andrew Nowalk3
1Division of Pediatric Cardiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA. cheyenne.beach@yale.edu.
Insights
Lyme disease and Lyme carditis hospitalizations increased significantly in US children's hospitals, with carditis cases being substantially costlier. This highlights the need for Lyme disease prevention and early detection.
Area of Science:
- Pediatric infectious diseases
- Epidemiology
- Health economics
Background:
- Lyme disease is a significant public health concern, particularly in children.
- Carditis is a serious complication of Lyme disease, potentially leading to increased healthcare utilization and costs.
- Understanding trends in Lyme disease and its cardiac manifestations is crucial for resource allocation and public health strategies.
Purpose of the Study:
- To characterize the changing epidemiology of Lyme disease and associated carditis in US children's hospitals.
- To evaluate resource utilization and associated costs for pediatric Lyme disease hospitalizations, comparing cases with and without carditis.
- To hypothesize about the burden and cost-effectiveness of Lyme carditis hospitalizations.
Main Methods:
- Utilized the Pediatric Health Information System (PHIS) database for encounters between 2007 and 2013.
- Identified Lyme disease cases and specifically Lyme carditis cases using diagnostic codes.
- Analyzed demographic, clinical, and resource utilization data, adjusting costs to 2014 US dollars.
Main Results:
- Lyme disease (360 to 672 cases) and Lyme carditis (17 to 40 cases) significantly increased in frequency, primarily in the Midwest.
- Carditis frequency among Lyme disease cases remained stable (p=0.15).
- Lyme carditis hospitalizations were significantly costlier than Lyme disease without carditis (median $9104 vs. $922, p<0.001).
Conclusions:
- The rise in pediatric Lyme carditis cases correlates with increased Lyme disease incidence, not altered virulence.
- Increased serious cardiac events and associated costs underscore the need for Lyme disease prevention and early detection.
- Effective control of Lyme disease spread is essential to mitigate severe outcomes and reduce healthcare expenditures.
Abstract:
We sought to characterize the shifting epidemiology and resource utilization of Lyme disease and associated carditis in US children's hospitals. We hypothesized that the Lyme carditis burden has increased and that hospitalizations for Lyme carditis are costlier than those for Lyme disease without carditis. The PHIS database was queried for Lyme disease encounters between January 1, 2007 and December 31, 2013. Additional diagnostic codes consistent with carditis identified Lyme carditis cases. Demographic, clinical, and resource utilization data were analyzed. All costs were adjusted to 2014 US dollars. Lyme disease was identified in 3620 encounters with 189 (5%) associated with carditis. Lyme disease (360 cases in 2007 vs. 672 in 2013, p = 0.01) and Lyme carditis (17 cases in 2007 vs. 40 in 2013, p = 0.03) both significantly increased in frequency. This is primarily accounted for by their increase within the Midwest region. Carditis frequency among cases of Lyme disease was stable (p = 0.15). Encounters for Lyme carditis are dramatically costlier than those for Lyme disease without carditis [median $9104 (3741-19,003) vs. 922 (238-4987), p < 0.001] The increase in Lyme carditis cases in US children's hospitals is associated with an increased Lyme disease incidence, suggesting that there has not been a change in its virulence or cardiac tropism. The increasing number of serious cardiac events and costs associated with Lyme disease emphasize the need for prevention and early detection of disease and control of its spread.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Endocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction

